Clinical biomedical research & surveillance in support of the armed forces research institute of medical sciences bangkok thailand
Ended Definitive Contract Awarded Last action
- Contract number
- HT942523C0081
- Awardee
-
Velez Ventures, Inc. UEI DRY4MFJ5JLK5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $374,176
Award facts
- Opportunity
-
- HT942523R0041 Solicitation number
- Contract value 16% obligated
-
- $1,038,077.20 Current, with exercised options
- $2,384,464.98 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Philippines
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $142,920 | |
| Exercise an Option | $124,821 | |
| Original award | $106,435 |
About this award
The Defense Health Agency awarded a definitive firm fixed-price contract to Velez Ventures, Inc. (UEI: DRY4MFJ5JLK5) on September 20, 2023, with a ceiling value of $2,384,464.98 and an ultimate completion date of September 21, 2028. The contract supports clinical biomedical research and surveillance activities in the Philippines focused on epidemiology and infectious disease prevention in support of the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand. This non-personal services contract was awarded without a set-aside designation and will be performed in the Philippines.
The contract represents the Defense Health Agency's investment in research infrastructure and disease surveillance capabilities in a strategically important region for military medical operations and public health threat assessment. The five-year performance period reflects the sustained nature of epidemiological research and surveillance programs, which require ongoing data collection, analysis, and reporting to support military readiness and inform infectious disease prevention strategies across the Indo-Pacific region.
Quick answers
Who was awarded contract HT942523C0081?
HT942523C0081 was awarded to Velez Ventures, Inc. by Defense Health Agency (Department of Defense) on September 20, 2023.
How much is contract HT942523C0081 worth?
The government has obligated $374,176 on HT942523C0081. Its current value, with exercised options, is $1,038,077. Its potential value, with all options, is $2,384,465.
Was contract HT942523C0081 competed?
The extent of competition for HT942523C0081 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award